CLINICAL PUBLICATIONS

 SR. NO. NAME OF PUBLISHED ARTICLE LINK TO THE ARTICLE AND KNOW MORE JOURNAL AND YEAR OF PUBLICATION NUMBER OF PATIENTS STUDY DESIGN FOLLOW-UP FIRST AUTHOR
Total Publications= 259
CARDIOVASCULAR (Total=233 articles)

Myval™ Transcatheter Heart Valve Replacement-Clinical Publications

(Total=98 articles)

Original Research Articles (39)

OR 39. Performance of balloon-expandable transcatheter bioprostheses in inoperable patients with pure aortic regurgitation of a native valve: The BE-PANTHEON international project OR 39. Cardiovascular Revascularization Medicine (2024) 41 out of 144 Patients Retrospective study 1 year Enrico Poletti, Italy
OR 38. Initial experience with the Myval balloon expandable valve in Argentina OR 38. Revista Argentina de Cardioangiología Intervencionista (2024)  300 Patients Prospective multi-center registry Post-procedure Federico Blanco, Argentina
OR 37. Early Outcomes of Transcatheter Aortic Valve Implantation With Next-generation Balloon-expandable Myval Transcatheter Heart Valve: Single-center Experience From Iraq OR 37. Journal of the Saudi Heart Association (2024)  100 Patients Prospective single-centre study  30 Days Khalid Amber, Iraq
OR 36. German Experience with a Novel Balloon-Expandable Heart Valve Prosthesis for Transcatheter Aortic Valve Implantation Outcomes of the MYLAND (MYvaL germAN stuDy) Study OR 36. Journal of Clinical Medicine
(2024)
134 Patients Investigator-initiated, multi-center, retrospective, observational study 30 Days

Timm Ubben, Germany

OR 35. LANDMARK trial: Randomised non-inferiority comparison of early outcomes of newer generation Myval THV series with contemporary valves (Sapien and Evolut THV series) in real-world Patients with severe symptomatic native aortic stenosis OR 35. The Lancet
(2024)
768 Patients RCT 30 Days Andreas Baumbach, UK
OR 34. Clinical outcomes of the Myval transcatheter heart valve system in Patients with severe aortic valve stenosis: a two-year follow-up observational study OR 34. Archives of Medical Science
(2024)
207 Patients Multi-centre, registry based, observational study 2 Years Teoman Kilic,
Turkey
OR 33. Multicenter Experience for Early and Mid-Term Outcome of MyVal Transcatheter Pulmonary Valve Implantation OR 33. Pediatric Cardiology
(2024)
53 Patients Multi-center, observational study 360 Days median follow-up Mohamed Al Nasef,
Saudi Arabia
OR 32. Safety and effectiveness of the novel Myval Octacor transcatheter heart valve in severe, symptomatic aortic valve stenosis – A real world Indian experience (The OCTACOR India Study) OR 32. Cardiovascular Revascularization Medicine
(2024)
123 Patients Multi-center, real-world observational registry 30 Days John Jose,
India
OR 31. Single-Center Experience with the Balloon Expandable Myval Transcatheter Aortic Valve System in Patients with Bicuspid Anatomy: Procedural and 30-Day Follow-Up OR 31. Journal of Clinical
Medicine
(2023)
52 Patients Retrospective,
observational
study
30 Days Balázs Magyari,
Hungary
OR 30. Clinical Outcomes Following Transcatheter Mitral Valve-in-Valve Replacement Using a Meril Myval Transcatheter Heart Valve OR 30. Heart, Lung and
Circulation
(2023)
20 Patients Retrospective,
observational,
single-centre
study
1 Year Mullasari Ajit Sankardas,
India
OR 29. Comparing two-year outcomes of balloon expandable Myval and self- expanding Evolut R in severe aortic valve stenosis OR 29. International
Journal of
Cardiology
(2023)

58 out of 166 Patients

Retrospective, single-center, observational,
cohort analysis
2 Years Elisabetta Moscarella,
Italy
OR 28. Single center experience with the balloon‐expandable Myval transcatheter aortic valve system with the first 100 Patients: 30‐day and 1‐ year follow‐up OR 28. Catheterization and
Cardiovascular
Interventions
(2023)
100
Patients
Retrospective,
single-center
study
1 Year Balázs Magyari,
Hungary
OR 27. Transcatheter Aortic Valve Replacement for Pure Native Aortic Valve Regurgitation: The PANTHEON International Project OR 27. JACC: Cardiovascular Interventions
(2023)
40 out of 69 Patients Retrospective study 1 Year Enrico Poletti,
Italy
OR 26. Performance of the 32 mm Myval transcatheter heart valve for treatment of aortic stenosis in Patients with extremely large aortic annuli in real- world scenario: first global, multi-centre experience OR 26. Catheterization and Cardiovascular Interventions
(2023)
10 Patients Retrospective, observational multi-center study 30 Days Andreas Holzamer,
Germany
OR 25. Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation OR 25. EuroIntervention (2023) 113 Patients International, multi-center, observational study 1 Year Juan Pablo Sánchez-Luna,
Spain
OR 24. Early Outcomes of a Next- Generation Balloon-Expandable Transcatheter Heart Valve – The Myval System: A Single-Center Experience from Serbia OR 24. Journal of Cardiology and Cardiovascular Medicine (2023) 13 Patients Retrospective, single center study 30 Days Darko Boljevic,
Serbia
OR 23. Assessing the Novel Myval Balloon-Expandable Valve with the Evolut Valve: A Propensity- Matched Study OR 23. Journal of Clinical Medicine
(2023)
120 out of 223 Patients Retrospective, single-center study 1 Year Jonathan Halim,
The Netherlands
OR 22. Angiographic quantification of aortic regurgitation following Myval Octacor implantation: Independent core lab adjudication OR 22. International Journal of Cardiology
(2023)
125 Patients Retrospective, core lab analysis - Ahmed Elkoumy,
Ireland
OR 21. Safety and performance parameters of the Myval transcatheter aortic valve bioprosthesis: The SAPPHIRE prospective registry OR 21. Cardiovascular Revascularization Medicine
(2023)
100 Patients Single-arm, prospective registry 2 Years Luca Testa,
Italy
OR 20. One-year outcomes after Myval implantation in Patients with bicuspid aortic valve stenosis-a multi-centre real-world experience OR 20. Journal of Clinical Medicine
(2023)
62 Patients Retrospective multi-centre study 13.5 months median follow-up Ahmed Elkoumy,
Ireland
OR 19. Latest iteration balloon and self-expandable transcatheter valves for severe bicuspid aortic stenosis: The TRITON study OR 19.

 

Revista Española de Cardiología
(2023)

122 out of 360 Patients Multi-centre, retrospective registry 30 Days Ignacio J Amat-Santos,
Spain
OR 18. Transcatheter valve-in-valve or valve-in-ring implantation with a novel balloon-expandable device in Patients with bioprosthetic left side heart valves failure:1-year follow-up from a multi-center experience OR 18. International Journal of Cardiology (2023) 97 Patients Prospective, multi-centre study 1 Year Elisabetta Moscarella,
Italy
OR 17. Transcatheter aortic valve implantation: a report on Serbia’s first systematic program OR 17. Frontiers in Cardiovascular Medicine
(2022)
13 out of 56 Patients Cohort study 30 Days Darko Boljevic,
Serbia
OR 16. Balloon-expandable TAVR bioprostheses: area or perimeter sizing? A prospective pilot study OR 16. Journal of Interventional Cardiology (2022) 60 Patients Prospective, single-centre study 1 Year Jonathan Halim,
The Netherlands
OR 15. Short-term outcome after transcatheter aortic valve replacement with a novel balloon-expandable valve OR 15. Netherlands Heart Journal
(2022)
120 Patients Prospective, single-centre study 6 Months Jonathan Halim,
The Netherlands
OR 14. Transcatheter mitral valve-in-valve implantation with the balloon expandable Myval device OR 14. Journal of Clinical Medicine
(2022)
11 Patients Multi-centre, retrospective study 6 Months Sara Blasco-Turrión,
Spain
OR 13. Transcatheter aortic valve implantation for severe bicuspid aortic stenosis-
2 years follow up experience from India
OR 13. Frontiers in Cardiovascular Medicine
(2022)
70 BAV
Patients of 287
Multi-centre study 2 Years Vijay Kumar,
India
OR 12. Clinical comparison of a novel balloon-expandable versus a self-expanding transcatheter heart valve for the treatment of Patients with severe aortic valve stenosis: the EVAL Registry OR 12. Journal of Clinical Medicine
(2022)
58 of 166
Patients
Retrospective, single-centre study 6 months Monica Barki,
Italy
OR 11. Feasibility of precise commissural and coronary alignment with balloon-expandable TAVI OR 11. Revista Española de Cardiología
(2022)
10 Patients Prospective study 1 Month Sandra Santos-Martınez,
Spain
OR 10. Safety and efficacy of Myval implantation in Patients
with severe bicuspid aortic valve stenosis-a multi-center real world experience
OR 10. Journal of Clinical Medicine
(2022)
68 Patients Retrospective study 30 Days Ahmed Elkoumy,
Ireland
OR 9. First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study OR 9. Herz Cardiovascular Diseases
(2021)
25 Patients Retrospective study 3 Months Ali Rıza Akyüz,
Turkey
OR 8. Myval™ versus alternative balloon-and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances OR 8. International Journal of Cardiology (2021) 135 out of
1131 Patients
Central corelab analysis, retrospective registry 1 Year Santos Martinez S,
Spain
OR 7. Early multicenter experience of a new balloon-expandable Myval™ transcatheter heart valve in dysfunctional stenosed right ventricular outflow tract conduits OR 7. Annals of Pediatric Cardiology
(2021)
7 Patients Retrospective, multi-centre study Median follow-up 16 months Muthukumaran C Sivaprakasam,
India
OR 6. Next-generation balloon-expandable Myval™ transcatheter heart valve in low-risk aortic stenosis Patients OR 6. Catheterization and Cardiovascular Interventions
(2021)
100 Patients Retrospective, multi-center registry 30 Days Mario Garcia-Gomez,
Spain
OR 5. Early clinical and haemodynamic matched comparison of balloon-expandable valves OR 5. Heart (2021) 130 of 416
Patients
Prospective study 30 Days Jose R Delgado-Arana,
Spain
OR 4. Operator preference and determinants of size selection when additional intermediate-size aortic transcatheter heart valves are made available OR 4. International Journal of Cardiology
(2021)
1115 Patients Retrospective survey - Hideyuki Kawashima,
Ireland
OR 3. Quantitative angiographic assessment of aortic regurgitation after transcatheter aortic valve implantation among three balloon-expandable valves OR 3. Global Heart (2021) 108 out of 744 Patients Retrospective, multi-center study Post- implantation aortography Hideyuki Kawashima,
Ireland
OR 2. Single-center experience of 105 minimalistic transfemoral transcatheter aortic valve replacement and its outcome OR 2. Indian Heart Journal (2021) 105 Patients Single-center, retrospective study 30 Days Ravinder Singh Rao,
India
OR 1. First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in Patients with severe symptomatic native aortic stenosis: the MyVal-1 study OR 1. EuroIntervention
(2020)
30 Patients First-in-human, prospective, multi-center, single-arm, open-label study 1 Year Samin K. Sharma,
USA
Abstracts (06)
AB 6. Commissural/Coronary Alignment with the Novel Myval™ Octacor THV-The Octa Align Technique AB 6. JACC: Cardiovascular Interventions
(2023)
30 Patients - - Pruthvi C. Revaiah,
Ireland
AB 5. Early single-center experience with Meril’s Myval transcatheter heart valve AB 5. JACC: Cardiovascular Interventions
(2022)
39 Patients Single-centre, single-arm,
open label, prospective
registry
30 Days Alberto Colella Cervone,
Brazil
AB 4. Safety and efficacy of Myval™ transcatheter heart valve for treatment of severe symptomatic aortic stenosis at 30‐days AB 4. Catheterization and Cardiovascular Intervention
(2020)
7 Patients Retrospective, cohort study 1 Month Nayef A. Al Asiri,
Saudi Arabia
AB 3. Implant of Myval transcatheter aortic valve in Patients with severe aortic stenosis AB 3. Structural Heart (2020) 5 Patients Prospective study 6 Months Andrea Janet Robaina Barrios,
Venezuela
AB 2. Clinical and haemodynamic outcomes of Patients who underwent transcatheter mitral valve-in-valve replacement: one- month results AB 2. The American Journal of Cardiology
(2020)
10 Patients - 1 Month Ravinder Singh Rao,
India
AB 1. Evaluation of balloon expandable transcatheter heart valve in the treatment of severe symptomatic native aortic stenosis: the first-in human MyVal-1 study AB 1. Structural Heart (2020) 100
Patients
First-in-man, prospective, multi-centre,
single-arm study
  1 Month Ravinder Singh Rao,
India
Case Reports (21)
CR 21. Technical Aspects for Transcatheter Aortic Valve Replacement with the Novel Balloon-Expandable Myval Octacor CR 21.

 

JACC:
Cardiovascular
Intervention
(2024)

 1 Patient  - Post-procedural Alfonso Ielasi,
Italy 
CR 20. Transcatheter aortic valve implantation for aortic regurgitation in HeartMate II supported patient using Myval THV: a case report CR 20. Oxford Medical Case
Reports
(2023)
 1 Patient  - 1 Year  Mohamad Hamieh,
Lebanon
CR 19. Case report: A complex case of valve-in-valve TAVI and left bundle branch pacing for severe aortic regurgitation with partially corrected type A aortic dissection and low ejection fraction CR 19. Frontiers in Cardiovascular Medicine (2023) 1 Patient - 1 Year Peter Marko Mihailovič,
Slovenia
CR 18. Pulmonary valve replacement in a large and tortuous right ventricle outflow tract with a 32 mm Myval valve under local anesthesia: challenges and technical considerations: a case report CR 18. European Heart Journal Case Reports (2023) 1 Patient - 3 Months Ali Houeijeh,
France
CR 17. Case report: a novel surgical technique for rapid valve-in-ring implantation into the native aortic annulus during left ventricular assist device implantation CR 17. Frontiers in Cardiovascular
Medicine
(2023)
1 Patient - 6 Months Yuriy Pya,
Kazakhstan
CR 16. Left ventricular assist device implantation combined with direct transaortic transcatheter valve-in-annular stent implantation after rescue mechanical Bentall procedure, a case report CR 16. BMC Journal of Cardiothoracic Surgery
(2023)
1 Patient - Post-procedural Yuriy Pya,
Kazakhstan
CR 15. In-series transcatheter aortic valve replacement-in-transcatheter aortic valve replacement: ACURATE neo transcatheter heart valve degeneration successfully managed with Myval, avoiding coronary flow obstruction-a case report CR 15. Structural Heart (2023) 1 Patient - 1 Month Joao Felipe Barros de Toledo,
Brazil
CR 14. Redo-transcatheter aortic valve implantation in a patient at high risk of coronary obstruction due to sinus sequestration CR 14. European Heart Journal (2023) 1 Patient - Post-procedural Ying-Hwa Chen,
Taiwan
CR 13. Under-deployed TAVI with occluded left-main and severe aortic regurgitation; bailout chimney-in-chimney stenting and aggressive post-dilatation saves the day CR 13. Clinical Case Reports (2022) 1 Patient - 1 Week Pandula Athauda-arachchi,
Sri Lanka
CR 12. Transcatheter mitral valve-in-valve replacement transeptally using a novel balloon-expandable device CR 12. Journal of Cardiac Surgery
(2022)
1 Patient - Procedural Details Maria Drakopoulou,
Greece
CR 11. Transcatheter treatment tricuspid regurgitation by valve-in-ring implantation with a novel balloon-expandable Myval™ THV CR 11. Clinical vignette Kardiologia Polska (2022) 1 Patient - Procedural Details Hüseyin Ayhan,
Turkey
CR 10. Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32mm Myval transcatheter heart valve CR 10. Catheterization and Cardiovascular Interventions
(2021)
1 Patient - 1 Year Alejandro Rodríguez Ogando,
Spain
CR 9. Transcatheter aortic valve implantation for aortic insuffiency in Patients with left ventricular assistance CR 9. Giornale Italiano di Cardiologia
(2021)
1 Patient - Post-procedural Marco B. Ancona, Milan,
Italy
CR 8. First-in-man valve-in-valve with the new balloon-expandable Myval™ transcatheter heart valve in a failed sutureless perceval bioprosthesis CR 8. Journal of Cardiac Surgery
(2021)
1 Patient - 30 Days Igor Belluschi,
Italy
CR 7. Transcatheter tricuspid valve-in-valve implantation with a novel balloon expandable Myval THV CR 7. The Annals of Thoracic Surgery
(2021)
1 Patient - 1 Month Bilge Duran Karaduman,
Turkey
CR 6. Tip-to-base lampoon to prevent left ventricular outflow tract obstruction in a valve-in-ring transcatheter mitral valve replacement: first LAMPOON procedure in turkey and first LAMPOON case for transseptal Myval™ implantation CR 6. Anatolian Journal of Cardiology
(2021)
1 Patient - 1 Month Teoman Kılıç,
Turkey
CR 5. Successful management of left main coronary artery obstruction following transcatheter aortic valve implantation CR 5. IHJ
Cardiovascular Case Reports
(2020)
1 Patient - Procedural Details Viveka Kumar,
India
CR 4. Myval™ and mini-chimney stenting to prevent coronary obstruction during full root stent-less aortic valve-in-valve procedure CR 4. Cardiovascular Revascularization Medicine
(2020)
1 Patient - 6 Months Alfonso Ielasi,
Italy
CR 3. Simultaneous percutaneous coronary intervention and transcatheter aortic valve implantation in a very high-risk
octogenarian patient-what’s ideal time?
CR 3. IHJ
Cardiovascular Case Reports
(2020)
1 Patient - 8 Months Pankaj Jariwala,
India
CR 2. First transcatheter pulmonary valve implantation-an Indian made valve CR 2. IHJ
Cardiovascular Case Reports
(2020)
1 Patient - 6 Months Muthukumaran Chinnasamy Sivaprakasam,
India
CR 1. Successful transcatheter aortic valve replacement in a kidney allograft patient on rapamycin CR 1. Indian Journal of Transplantation (2019) 1 Patient - Procedural Details Aashish Chopra,
India
Case Series (8)
CS 8. A new simple technique for stabilizing the guidewire position within the left ventricle during transcatheter mitral valve‐in‐valve implantation CS 8.

Catheterization and Cardiovascular Interventions (2024)

2 Patients - Post-procedure Kothandam Sivakumar, India
CS 7. Transcatheter Aortic Valve Implantation in Two High-Risk Patients with Low Coronary Ostial Heights Using the Novel Balloon Expandable MyvalTM Valve CS 7.

Journal of Cardiology
And Cardiovascular
Medicine
(2023)

2 Patients - 1 Month Raja Ramesh N,
India
CS 6. Case report: Transcatheter tricuspid valve-in-valve implantation using novel balloon-expandable aortic valve with 1 year follow-up CS 6.

Frontiers in Cardiovascular
Medicine
(2023)

5 Patients - 1 Year Abdurashid Mussayev,
Kazakhstan
CS 5. Transcatheter mitral valve replacement (TMVR) for degenerated mitral valve bioprosthesis-A case series CS 5.

IHJ Cardiovascular Case Reports
(2023)

5 Patients - 1 Month Viveka Kumar,
India
CS 4. TAVR in a large bicuspid anatomy using the XL-Myval™ 32mm CS 4. Frontiers in Cardiovascular Medicine (2022) 3 Patient - 30 Days Ahmed Elkoumy,
Ireland
CS 3. Two case reports of transcatheter valve-in-valve implantation of Sapien 3 and MyVal in degenerated biological tricuspid prosthesis valves CS 3.

European Heart Journal
(2022)

2 Patients - 6 Years Rebekka Vibjerg Jensen,
Denmark
CS 2. First experiences with Myval™ transcatheter heart valve system in the treatment of severe pulmonary regurgitation in native right ventricular outflow tract and conduit
dysfunction
CS 2.

Cardiology in the Young
(2021)

9 Patients - 9.8 months mean follow up Ender Odemis,
Turkey
CS 1. Trans-catheter valve-in-valve implantation with a novel balloon expandable device in Patients with bioprosthetic heart valve failure: A case series CS 1.

Cardiovascular Revascularization Medicine
(2020)

5 Patients - Post-procedural Alfonso Ielasi,
Italy
Editorial/ Editorial Letters (09)
EL9. BASELINE trial: update in study design EL9. American Heart Journal (2024) - Protocol update  

Rutger-Jan Nuis,

The Netherlands

EL8. Novel 35-mm Balloon-Expandable Transcatheter Aortic Valve Replacement EL8. JACC: Cardiovascular Interventions
(2024)
- - - John Jose,
India
EL7. LANDMARK trial: Update in study protocol EL7. American Heart Journal
(2024)
- - - Akihiro Tobe,
Ireland
EL6. Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now? EL6. REC:
Inteventional
Cardiology
(2024)
- - - Ignacio J. Amat Santos,
Spain
EL5. Bicuspid aortic valve: one of the last remaining challenges for the percutaneous treatment of aortic valve disease EL5. Revista Española
de Cardiología
(2023)
- - - Pilar Jimenez Quevedo,
Spain
EL4. Neocommissural/ Coronary Alignment with a Novel Balloon Expandable Transcatheter Aortic Valve First-in-Human Experience EL4. JACC: Cardiovascular Interventions
(2023)
32 Patients - - Pruthvi C.Revaiah,
Ireland
EL3. Transcarotid transcatheter aortic valve implantation with a novel balloon expandable Myval™ THV under
the local anesthesia
EL3. Journal of Geriatric Cardiology
(2022)
1 Patient - - Hüseyin Ayhan,
Turkey
EL2. Transcatheter Pulmonary Valve Replacement With 32-mm Balloon-Expandable Prosthesis: Another Strategy in Mildly Dilated RVOT EL2. JACC:
Cardiovascular Interventions (2021)
- - - Marco B. Ancona,
Italy
EL1. (Intermediate) size matters  EL1. International Journal of Cardiology
(2021)
1 Patient -  - Won-Keun Kim,
Germany
Case Images (01)
CI 1. Valve-in-Valve TAVR for Large Degenerated Bioprosthetic Valves:The Added Value of XL-32 mm MyVal Octacor CI 1. Canadian Journal of Cardiology (2024) 1 Patient -
-  Mariano Pellicano, Italy
Systematic Review (01)
SR 1. The novel balloon-expandable Myval transcatheter heart valve: systematic review of aortic, mitral, tricuspid and pulmonary indications SR 1. Revista Española de Cardiología (2024) 74 Patients -
- Mario Garcia Gomez, Spain
Review Articles (07)
RA 7. A novel balloon-expandable transcatheter aortic valve bioprosthesis: Myval and Myval Octacor RA 7. Expert Review of Cardiovascular Therapy (2024) - -

-

Carolina Montonati,Italy
RA 6. Myval: a novel transcatheter heart valve for the treatment of severe aortic stenosis RA 6. Interventional Cardiology Review, Research, Resources
(2023)
- -

-

Ashok Seth,
India
RA 5. Prosthesis tailoring for Patients undergoing transcatheter aortic valve implantation RA 5. Journal of Clinical Medicine
(2023)
- -

-

Pier Pasquale Leone,
USA
RA 4. An update on new generation transcatheter aortic valves and delivery systems RA 4. Journal of Clinical Medicine
(2022)
- -

-

Gloria Santangelo,
Italy
RA 3. Choice of transcatheter heart valve: should we select the device according to each patient’s characteristics or should it be “one valve fits all”? RA 3. Annals of Translational Medicine
(2020)
- -

-

Matthias Renker,
Germany
RA 2. Myval transcatheter heart valve system in the treatment of severe symptomatic aortic stenosis RA 2. Future Cardiology (2020) - -

-

Samin K Sharma,
USA
RA 1. Current status of transcatheter aortic valve replacement in India RA 1.
Cardiovascular Diagnosis and Therapy
(2019)
- -

 -

Puneet Gupta,
India
Scientific Letter (01)
SL 1. Balloon-expandable Myval transcatheter aortic valve implantation. First experience in
Spain
SL 1. Revista Espanola de Cardiologia
(2020)
2 Patients -
 Discharge Sandra Santos-Martınez,
Spain
Scientific Report (01)
SR 1. Angulation and curvature of aortic landing zone affect implantation depth in transcatheter aortic valve
implantation
SR 1. Scientific Report
(2024)
81 Implants Observational, retrospective and single-center registry
 Index Procedure Riccardo Gorla,
Italy
Study Protocols (02)
SP 2. Randomized comparison of TAVI valves: The Compare-TAVI trial SP 2. American Heart Journal
(2024)
- RCT - Christian Juhl Terkelsen, Denmark
SP 1. Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in Patients with severe symptomatic aortic valve
stenosis: The LANDMARK trial
SP 1. American Heart Journal
(2021)
- Prospective, randomized, multi-national, multi-centre, open-label, non-inferiority trial  
Hideyuki Kawashima,
Ireland
Comment (02)
C 2. Myval Balloon-Expandable Prosthesis in Argentina: Time to Take the Bull by the Horns NA Revista Argentina de Cardioangiología Intervencionista (2024) 300 Patients Prospective multi-center registry Post-procedure Federico Blanco, Argentina
C 1. New-generation Myval transcatheter heart valve in severe aortic stenosis C 1. THE LANCET
(2024)
384 Patients RCT 30 Days Mariama Akodad, France
BioMime™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total=44 articles)
Original Research Articles (10)
OR 10. Real-world evidence of BioMime sirolimus-eluting stent in obstructive coronary artery disease: the meriT-2 trial OR 10. AsiaIntervention (2024) 250 Patients Prospective, single-arm, multicentre study 5 Years Upendra Kaul, India
OR 9. Long-Term Assessment of Thin-Strut BioMime Coronary Stent System in Real-World Population at Single-Center: A Retrospective Observational Study OR 9. Cardiology Research
(2023)
1188 Patients Retrospective, observational, single-center, post- marketing clinical follow-up study 4 Years Girish Meennahalli Palleda,
India
OR 8. A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent with Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial OR 8. Cardiology Research (2023) 170 out of 256 Patients Randomized, active-controlled, non-inferiority trial, prospective, multi-center 2 Years Alexandre Abizaid,
Brazil
OR 7. Clinical follow-up of long non-tapered sirolimus-eluting coronary stent in real-world Patients with de novo lesions.The Billar registry OR 7. REC Interventional Cardiology
(2022)
696 Patients Prospective, non-randomized, multi-centre study   1 Year Enric Domingo Ribas,
Spain
OR 6. Clinical outcomes of biodegradable polymer sirolimus-eluting stent in coronary artery lesions Patients: a
retrospective analysis
OR 6. EC Cardiology (2020) 73 Patients Retrospective, single-center, non-randomized and
observational study
  2 Years Binu Thankappan Gomathy,
India
OR 5. Single long stents versus overlapping multiple stents in the management of very long coronary lesions: comparisons of procedures and clinical outcomes OR 5. The Journal of Tehran University Heart Center
(2019)
124 out of 1709 Patients Historical cohort study 1 Year Alireza Amirzadegan,
Iran
OR 4. Randomized comparison of biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting coronary stent in Patients with de novo native coronary artery lesions:
the meriT-V trial
OR 4.

 

EuroIntervention
(2018)

170 out of 256 Patients Prospective, multi-centre, randomized, open
label, active-controlled, and
non-inferiority trial
9 Months Alexandre Abizaid,
Brazil
OR 3.  One-year outcomes of a BioMime™ sirolimus-eluting coronary stent system with a biodegradable polymer in all-comers coronary artery disease Patients: The meriT-3 study OR 3.

Indian Heart Journal (2016)

1161 Patients Retrospective, multi-center study  1 Year Rajendra Kumar Jain,
India
 OR 2.  Late angiographic and clinical outcomes of the novel BioMime™ sirolimus-eluting coronary stent with ultra-thin cobalt-chromium platform and biodegradable polymer for the treatment of diseased coronary vessels:results from the prospective, multi-centre meriT-2 clinical trial OR 2.

 AsiaIntervention (2016)

250 Patients Prospective, non randomised, single-arm, multi-centre study 1 Year  Ashok Seth,
India
 OR 1. First-in-human evaluation of the novel BioMime™ sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels-results from the meriT-1 trial OR 1. EuroIntervention (2013) 30 Patients Prospective, non-randomised, single-arm, single-centre study  1 Year Sameer Dani,
India
Meta-Analysis (02)
MA 2. Long-term follow-up after ultrathin vs. conventional 2nd generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials MA 2. European Heart Journal (2021)  170 out of 256 Patients Meta-analysis of 16 trials that randomized 20,701 Patients 2.5 Years (mean follow-
up)
Mahesh V. Madhavan,
USA
MA 1. Newer generation ultra-thin strut drug- eluting stents versus older second- generation thicker strut drug-eluting stents for coronary artery disease: a meta-analysis of randomized trials. MA 1. Circulation (2018) 170 Patients out of 11,658 Patients Meta-analysis of 10 trials that randomized 11,658 Patients  1 Year Sripal Bangalore,
USA
Abstracts (16)
AB 16. Strut coverage of the ultrathin BioMime™ stent: a single-centre experience from the MILES-UK registry AB 16. EuroIntervention (2020) 28 Patients Prospective, OCT analysis 3 Months Sudipta Chattopadhyay,
United Kingdom
AB 15. Primary efficacy and safety outcomes of a sirolimus-eluting thin-strut coronary stent system in all-comer Patients undergoing PCI:the MILES-UK registry AB 15. EuroIntervention (2020) 752 Patients Prospective, non-randomized, multi-center, open label, observational registry 9 Months Ian Menown,
United Kingdom
AB 14. Safety and efficacy of sirolimus-eluting stent system in all-comers real-world population with coronary artery stenosis: the MILES-GLOBAL study AB 14. EuroIntervention (2020) 520 Patients Multi-center, prospective, single-arm, open-label study 1 Year Martin Hudec,
Slovakia
AB 13. Safety and performance of the biodegradable polymer-coated ultrathin strut sirolimus-eluting coronary stent system for very long lesions: 12-month
experience in real-world clinical practice
AB 13. EuroIntervention (2020) 216 Patients Retrospective, single-centre study 2 Years Vivek Jindal,
India
AB 12. Clinical outcomes from real-world Patients treated with biodegradable polymer coated ultrathin-strut sirolimus-eluting coronary stent system BioMime™ GBPR AB 12. EuroIntervention (2020) 1003 Patients Retrospective, single centre study 2 Years Vishal Batra,
India
AB 11. One-year clinical outcomes in Patients implanted with biodegradable polymer coated ultra-thin strut sirolimus-eluting coronary stent system for the treatment of very long (≥40mm) lesions AB 11. Journal of the American College of Cardiology (2019) 216 Patients Retrospective single-center study 1 Year Mohit Gupta,
India
AB 10. Safety and efficacy of sirolimus-eluting stent system in all-comers real-world population with coronary artery stenosis: the MILES-GLOBAL study AB 10. Journal of the American College of Cardiology (2019) 520 Patients Multi-centre, prospective, single-arm,
open-label study
1 Year Martin Hudec,
Slovakia
AB 9. Twelve-months clinical outcomes comparing biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting coronary stents in Patients with de novo native coronary artery lesions: the meriT-V randomized trial AB 9. Journal of the American College of Cardiology (2018) 170 out
of 256 Patients
Prospective,
multi-centre, randomized, active controlled, non-inferiority clinical trial
 1 Year Alexandre Abizaid,
Brazil
AB 8. Single long stent vs. overlapping multiple stents in the management of very long coronary lesions: comparison
of success rates and one-year clinical outcomes
AB 8. EuroIntervention (2018) 124 out of 1709 Patients Historical cohort study 441 ± 361 Days A.Amirzadegan,
Iran
AB 7. Efficacy and safety of an ultrathin strut sirolimus eluting stent with biodegradable polymer in all-comers Patients undergoing coronary intervention AB 7. European Heart Journal Supplement
(2018)
588 Patients Prospective, non-randomised, multi-centre, open label, observational registry 9 Months Ian Menown,
United Kingdom
AB 6. Three-year clinical outcomes of BioMime™ sirolimus-eluting coronary stent system with a biodegradable polymer in coronary artery disease Patients: a long-term follow-up of the meriT-2 study AB 6. Journal of the American College of Cardiology (2017) 250 Patients Prospective,
multi-center study
3 Years Ashok Seth,
India
AB 5. How to make a deal with distal left main coronary artery type A trifurcation lesion AB 5. Journal of the American College of Cardiology (2017) 1 Patient Case study Procedural Details Yusra Pintaningrum,
Indonesia
AB 4. Efficacy of the novel BioMime™ sirolimus-eluting stents with a biodegradable polymer in the treatment of de novo coronary lesions: an angiographic sub-analysis of the combined meriT-1 and meriT-2
prospective clinical trials
AB 4. Journal of the American College of Cardiology (2013) 280 Patients Sub-analysis of combined meriT-1 and meriT-2 prospective clinical trials Angiographic analysis at 8 months of both studies Ricardo A. Costa,
Brazil
AB 3. First-in-human evaluation of a novel sirolimus-eluting stent with a bioabsorbable polymer for the treatment of single, de novo, non-complex coronary lesions AB 3. Journal of the American College of Cardiology (2012) 30 Patients Prospective, non-randomized, single-arm, single-center study 8-month angiographic and 1-year clinical follow-up Erlon de Abreu Silva,
Brazil
AB 2. Impact of the new BioMime™ sirolimus-eluting stent in complex Patients of daily practice-preliminary results of the meriT-2 study AB 2. Journal of the American College of Cardiology (2012) 242 Patients Prospective, non-randomized, multi-center study 8-month angiographic and 1-year clinical follow-up Erlon de Abreu-Silva,
Brazil
AB 1. Moving towards biomimicry-development of novel BioMime™ sirolimus eluting coronary stent system AB 1.
The American Journal of Cardiology
(2011)
250 Patients Single-arm, multi-center study 1-month clinical outcome and 8-month
angiographic outcomes
Ashok Seth,
India
Review Articles (05)
RA 5. Ultrathin struts drug-eluting stents: a state-of-the-art review RA 5. Journal of Personalized Medicine
(2022)
- - - Attilio Leone,
Belgium
RA 4. Novel bioabsorbable polymer and polymer-free metallic drug-eluting stents RA 4. Journal of Cardiology (2018) - - - Jason Nogic,
Australia
RA 3. Innovative DES technologies from Meril RA 3. Minerva Cardioangiologica (2015) - - - Sanjeev Bhatt,
India
RA 2. Advantages of novel BioMime™ sirolimus eluting coronary stent system. Moving towards biomimicry RA 2. Minerva Cardioangiologica (2012) - - - Upendra Kaul,
India
RA 1. Moving towards Biomimicry-the development of the novel BioMime™ sirolimus eluting coronary stent system RA 1. European Cardiology Review
(2010)
- -  - Ashok Seth,
India
Case Reports (08)
CR 8. Cuspal dissection of aorta during percutaneous coronary intervention to left anterior descending artery managed successfully CR 8. IHJ
Cardiovascular Case Reports (2018)
1 Patient - Post-procedural Shilpa Jayaprakash,
India
CR 7. Bifurcation stenting. It’s easy.
That’s what I thought
CR 7. Journal of the American College of Cardiology (2016) 1 Patient - Post-procedural Mohan Ramachandran,
Malaysia
CR 6. Inter-coronary communication in chronic total occlusion: in search of recognition CR 6. Indian Heart Journal (2016) 1 Patient - 6 Months Mohit Gupta,
India
CR 5. Chronic total occlusion intervention with no-flow tackled successfully CR 5. Journal of the American College of Cardiology (2015) 1 Patient - Post-procedural Arvind Kumar Kandoria,
India
CR 4. Ostial circumflex stenting through left main-LAD stent: a challenge of access in tortuous complex circumflex anatomy CR 4. Journal of the American College of Cardiology (2015) 1 Patient - Procedural Details Gurunath P. Parale,
India
CR 3. In-situ intra procedure left main coronary artery thrombosis CR 3. Journal of the American College of Cardiology (2014) 1 Patient - Procedural Details Puneet Verma,
India
CR 2. A percutaneous coronary intervention complication: coronary perforation CR 2. Journal of Turgut Ozal Medical Center
(2013)
1 Patient - Procedural Details Abdulmek Yildiz,
Turkey
CR 1. IVUS guided stenting in moderate looking
proximal coronary lesion
CR 1. Journal of Indian College of Cardiology
(2013)
1 Patient -  Post-procedural Aniket Puri,
India
Review Report/Scientific Reports (02)
RR 2. Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents RR 2. Nature (2020) - -   - Pawel Gasior,
Poland
RR 1.
BioMime a sirolimus-eluting coronary stent system for the treatment of Patients with de novo coronary lesions-meriT-1 report RR 1. Interventional Cardiology Review, Research, Resources
(2011)
30 Patients Prospective, single-arm,
single-center study
  1 Year Clinical Trial Department, Meril Life Sciences,
India
Commentary (01)
C 1. Very long stent technology: clinical and practical value C 1.
Future Cardiology
(2013)
- - -  Ian Menown,
United Kingdom

BioMime Branch™ Sirolimus Eluting Coronary Side Branch Stent System-Clinical Publication

(Total= 02 article)

Original Research Article (01)
OR 1. Coronary Bifurcation Lesion Treatment with the BioMime™ Branch Sirolimus-Eluting Coronary Side-Branch Stent System: A Single-Center Experience OR 1. Cardiovascular Revascularization Medicine (2024) 58 Patients Retrospective, single-center study 18 Months

Antonio L. Bartorelli, Italy

Abstract (01)
AB 1. BioMime™ Branch-1: a randomized comparison of sirolimus-eluting coronary side branch stent systems and everolimus-eluting stent systems to assess safety and performance in Patients with de novo coronary
bifurcation lesions
AB 1. EuroIntervention (2020) 18 out of 24 Patients Prospective, active-control, open-label,
multi-center, randomized clinical trial
6 Months

Sethuraman Selvamani,
India

BioMime™ Morph Sirolimus Eluting Tapered Coronary Stent System-Clinical Publications (Total=32 articles)
Original Research Articles (12)
OR12. Long-Term Safety and Performance of BioMime™ Morph Sirolimus-Eluting Coronary Stent System for Very Long Coronary Lesions OR12. Cardiology Research (2024) 88 Patients Prospective, single-center, observational, real-world, post-marketing surveillance study  3 Years Suresh V. Patted,
India
OR11. Real-world experience with a
60 mm long stent in the setting of primary percutaneous coronary intervention
OR11. Heart Views
(2022)
88 Patients Retrospective, observational analysis 1 Year Babu Thevan,
Kingdom of Bahrain
OR10. Percutaneous Intervention in Diffuse Coronary Disease: Overlapping Versus Single Very Long Stent Technique. Results From the OVERLONG Registry OR10. Angiology
(2021)
678 Patients Observational, retrospective, and single-center study Median
follow-up
31 months
Martín Negreira-Caamaño,
Spain
OR9. One-year outcomes of novel BioMime™ Morph tapered stent in long and multiple coronary artery
lesions
OR9. Anatolian Journal of Cardiology
(2021)
172 Patients Observational, retrospective, single-center study 1 Year Yash Paul Sharma,
India
OR8. Feasibility and outcomes of left main to branch vessel PCI with novel tapered coronary stent in a tertiary care center: a real-world experience OR8. Cardiovascular and Hematological Disorders Drug Targets
(2021)
41 Patients Prospective,
non-randomised, single-centre
study
Median
follow-up
20 months
T.R.Raghu,
India
OR7. Real-world experience with a tapered biodegradable polymer-coated sirolimus-eluting stent in Patients with long coronary artery stenosis OR7. Cardiology Research
(2020)
272 Patients Prospective, observational,
and multi-centre study
1 Year Alessandro Lupi,
Italy
OR6. Clinical experience with 12-month follow-up in Patients after implantation of a novel long tapered sirolimus drug-eluting stent OR6. Advances in Interventional Cardiology (2019) 32 Patients Prospective clinical cohort study 1 Year Jakub Podolec,
Poland
OR5. Feasibility of implanting 50-60 mm-tapered drug eluting stents in chronic total occlusions OR5. Cardiovascular Revascularization Medicine (2019) 51 out of
54
Patients
Retrospective, single-arm study A median follow-up of 330 (149-551)
days
Gema Miñana,
Spain
OR4. Comparison of clinical outcomes between very long stents and overlapping stents for the treatment of diffuse coronary disease in real clinical practice OR4. Cardiovascular Revascularization Medicine (2018) 628 Patients Single-centre, retrospective,
observational study
Median
follow-up of 20 months
Alfonso Jurado Román,
Spain
OR3. Clinical outcomes of novel long-tapered sirolimus-eluting coronary stent system in real-world Patients with long diffused de novo coronary lesions OR3. Cadiology Research
(2018)
362 Patients Retrospective, non-randomized, multi-centre
study
1 Year Suresh V. Patted,
India
OR2. First report of the use of long-tapered sirolimus-eluting coronary stent for the treatment of chronic total occlusion with the hybrid algorithm OR2. Catheterization Cardiovascular Interventions (2018)

 

49 out of
100 Patients

Observational retrospective study 303 ± 179
Days
Carlo Zivelonghi,
The Netherlands
OR1. First experience with the use of extra-long (40 to 60 mm) sirolimus-eluting stents in Patients with diffuse long
coronary lesions
OR1. Kardilogiya
(2017)
85 Patients Prospective, single-centre study 1 Year Yu G Matchin,
Russia
Abstracts (08)
AB8. Longitudinal stent deformation detected on coronary CT in the novel BioMime™ 60mm long sirolimus-eluting tapered stent AB8. EuroIntervention (2020) 20 Patients Prospective, single-centre study 6-9 Months Silvia Homs,
Spain
AB7. Clinical outcome of the world’s first tapered sirolimus-eluting coronary stent system for long coronary lesions:
a real-world experience
AB7. EuroIntervention (2020) 435 Patients Prospective, single-arm, multi-centre, real-world study 1 Year Deepak Davidson,
India
AB6. First Experience with very long coronary drug
eluting stent
AB6. Journal of the American College of Cardiology (2019) 63 Patients Retrospective
study
1-3 Months Farhat Fouladvand,
Italy
AB5. Initial experience with the novel BioMime™ Morph 40-60 mm long sirolimus-eluting tapered stent in long coronary lesions AB5. EuroIntervention (2018) 55 Patients Prospective,
single-centre study
200 ± 50 Days Anirban Choudhary,
United Kingdom
AB4. Multicenter clinical outcomes of hybrid tapered sirolimus-eluting coronary stent system with biodegradable polymer in long diffuse de novo
coronary artery lesions
AB4. EuroIntervention (2018) 362 Patients Retrospective, multi-center, non-randomized
study
6 Months Suresh V.Patted,
India
AB3. Real World Experience of the BioMime™ Morph tapered stent in a Tertiary Care Hospital AB3. Journal of the American College of Cardiology (2018) 122 Patients Retrospective observational study 26 Months Sanjai Pattu Valappil,
India
AB2. Experience of the management of complex long lesion by Indigenous BioMime™ Morph tapering stents AB2. Journal of the American College of Cardiology (2017) 52 Patients Prospective, observational study 9 Months Manotosh Panja,
India
AB1. Long term outcome after revascularization of long coronary artery lesions with very long or
overlapping stents. Insights from the propensity score matched registry
AB1. Journal of the American College of Cardiology (2017) 123 out of 377
Patients
Prospective, multi-centre registry 2 Years Piotr Buszman,
Poland
Case Reports (09)
CR9. Use of BioMime™ Morph stent in
treating left main triple vessel disease: a case report
CR 9. The Egyptian Heart Journal (2020) 1 Patient - 6 Months Yash Paul Sharma,
India
CR8. Successful treatment of tandem calcific right coronary artery stenoses with 50 mm tapered BioMime™ Morph stent guided by intravascular ultra sound and rotablation using a sheath less guide
via the radial access
CR 8. IHJ
Cardiovascular Case Report (2019)
1 Patient - 1 Year Baskar Sekar,
United Kingdom
CR7. Acute stent loss and its retrieval of a long, tapering Morph stent in a tortuous, calcified lesion CR 7. Cardiology Research (2018) 1 Patient - Post-procedural Santosh Kumar Sinha,
India
CR6. Tapered stents in long diffusely diseased coronary arteries-our experience CR 6. Journal of the American College of Cardiology (2017) 1 Patient - 2 Years T.R. Raghu,
India
CR5. The perfect storm CR 5. Journal of the American College of Cardiology (2017) 1 Patient - Post-procedural Jayakhanthan Kolanthaivelu,
Malaysia
CR4. Management of long complex CTO in LCX by indigenous BioMime™ Morph tapering stents from Meril CR 4. Journal of the American College of Cardiology (2017) 1 Patient - Post-procedural Manotosh Panja,
India
CR3. Intravascular ultrasonography guided 60-mm long drug-eluting tapered stent implantation in a long-calcified lesion in a patient with stable coronary artery disease CR 3. Advances in International Cardiology
(2017)
1 Patient - Post-procedural Jakub Podolec,
Poland
CR2. First in Poland, unique 60-mm long single drug eluting tapered stent
implantation in a patient with unstable angina
CR 2. Polish Heart Journal (2017) 1 Patient -  Post-procedural Jakub Podolec,
Poland
CR1. A report of successful procedural, clinical, and angiographic outcomes with a tapered stent of a patient in naturally tapered coronary vessel CR 1. Journal of Clinical and Diagnostic Research
(2017)
1 Patient - 1 Year Rajendra Kumar Premchand,
India
Short Report (01)
SR1. Initial Experience with the novel BioMime 60mm-long sirolimus-
eluting tapered stent system in long coronary lesions
SR 1. EuroIntervention
(2017)
50 Patients Prospective clinical cohort study Median follow-up 275 Days Ernesto Valero,
Spain
Commentary (01)
C1. Innovative DES technologies from
Meril
C1. Minerva Cardiology
and Angiology
(2015)
- -  - Sanjeev Bhatt,
India
Editorial (01)
E1. Treatment of long coronary lesions with single stent: BioMime Morph sirolimus-eluting tapered coronary stent system E1. Heart India
(2018)
- - - Suresh V. Patted,
India

BioMime™ Aura Sirolimus Coronary Eluting Stent System-Clinical Publications

(Total=02 articles)

Original Research Article (01)
OR1. Endovascular reconstruction of popliteal and infrapopliteal arteries for limb salvage and wound healing in Patients with critical limb ischemia-A retrospective analysis OR 1. Indian Heart Journal (2016) 34 Patients Retrospective analysis 3 Months Uday B. Khanolkar,
India
Case Report (01)
CR1. Multiple coronary microfistulas between left anterior descending artery and left ventricle
following myocardial infarction
CR 1.
Heart India (2017) 1 Patient - Post-procedural Sulaiman S,
India
Evermine50™ EES-Drug Eluting Stent-Clinical Publications (Total=12 articles)
Original Research Articles (05)
OR 5. Clinical safety and performance of the world’s thinnest strut Evermine50™ Everolimus-eluting stent: A 24-month follow-up of Evermine50 EES-1 study OR.5 AsiaIntervention (2024) 118 Patients Prospective, single-arm, multi-center study 2 Years Sivaprasad K, India
OR 4. Procedural safety and outcome of ultrathin strut stents (<60 μm) in the management of very long coronary artery stenosis (>30 mm)-
A retrospective real-world study
OR.4 American Journal of Cardiovascular Disease (2020) 65 out of 156 Patients Retrospective analysis, observational study 8.4 ± 13.9
months mean follow up
Soumya Patra,
India
OR 3. Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus eluting stent in Patients with coronary artery disease OR.3 ARYA Atherosclerosis
(2020)
171 Patients Retrospective study,
single-arm,
all-comers, single-center study
1 Year Suresh V. Patted,
India
OR 2. Clinical safety and efficacy of world’s thinnest (50μm), very long (>40 mm)
everolimus eluting stent among real world Patients
OR.2 American Journal of Cardiovascular Disease (2020) 711 Patients Prospective, observational study 1 Year Santosh Kumar Sinha,
India
OR 1. Clinical outcomes of world’s thinnest (50μm) strut biodegradable polymer coated everolimus eluting coronary stent system in real-world Patients OR.1 Cardiology Research
(2018)
251 Patients Prospective, single-arm, single-center, post marketing study 6 Months Suresh V. Patted,
India
Editorial (02)
E 2. Less is more: a new “thin-king” for DES? E.2 - - -   Azfar G. Zaman, United Kingdom
E 1. Biodegradable polymer Evermine50™
everolimus eluting coronary stent system with ultrathin (50μm) strut
E.1 Integrative Clinical Medicine
(2018)
- - - Suresh V. Patted,
India
Case Series (01)
CS 1. Device embolization during trans-radial percutaneous coronary intervention: Various approaches.
A case series
CS.1 IHJ Cardiovascular Case Reports
(2021)
3 Patients - - Nagamani Alur Chikkabasavaiah,
India
Abstracts (04)
AB 4. One-year clinical outcomes of ultrathin strut everolimus-eluting coronary
system (50µm) for treatment of patient with de novo coronary artery lesions
AB.4 AsiaIntervention (2019) 171 Patients Retrospective, single-arm,
observational study
1 Year Suresh V. Patted,
India
AB 3. 1-year clinical outcomes after percutaneous coronary intervention with biodegradable polymer ultra-thin strut everolimus-eluting coronary stent system AB.3 Journal of the American College of Cardiology (2019) 251 Patients Prospective, single-arm,
single-center, real-world study
1 Year Suresh V. Patted,
India
AB 2. Initial experience with ultrathin strut biodegradable polymer-coated everolimus-eluting coronary stent in coronary artery disease Patients AB.2 Journal of the American College of Cardiology (2018) 110 Patients Prospective, non-randomized, multi-center study 6 Months K. Sivaprasad,
India
AB 1. Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting coronary stent system in treatment of patient with de novo coronary artery lesions AB.1 EuroIntervention (2018) 171 Patients Single-arm, single-center, non-randomized study 1 Year Suresh V. Patted,
India
MeRes100™ Sirolimus Eluting BioResorbable Vascular Scaffold System-Clinical Publications (Total=19 articles)
Original Research Articles (04)
OR4. Imaging and two-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold:
the MeRes-1 extend trial
OR4. Catheterization and Cardiovascular Interventions
(2020)
64 Patients Prospective,
multi-centre, single-arm,
open-label
study
2 Years Alexandre Abizaid,
Brazil
OR3. Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold:
MeRes-1 trial
OR3. EuroIntervention (2019) 108
Patients
Prospective, multi-center, single-arm, open-label
clinical trial
3 Years Ashok Seth,
India
OR2. Pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system for treatment of de novo native coronary lesions: a sub-study of
MeRes-1 trial
OR2. Cardiology Research (2018) 10 Patients Prospective, single-arm, open-label pilot
study
90 days Praveen Chandra,
India
OR1. First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial OR1. EuroIntervention (2017) 108 Patients Prospective, multi-center, single-arm study 1 Year Ashok Seth,
India
Abstracts (09)
AB9. The MeRes-1 Extend trial: 2-year clinical and 6-month imaging outcomes of thin-strut sirolimus-eluting BRS in Patients with de novo coronary artery lesions AB 9. Journal of the American College of Cardiology (2020) 64 Patients Prospective,
multi-centre, single-arm study
Imaging follow-up at 6 months and clinical follow-up at 2 years Alexandre Abizaid,
Brazil
AB8. Clinical and imaging outcomes of thin-strut sirolimus eluting BRS in Patients with de novo coronary artery lesions: the MeRes-1 extend trial AB 8. EuroIntervention (2020) 64 Patients Prospective,
multi-centre, single-arm study
Angiographic follow-up at
6 months and clinical
follow-up upto 24 months
Alexandre Abizaid,
Brazil
AB7. Implantation of thin-strut sirolimus-eluting bioresorbable vascular scaffold in Patients with de novo coronary artery lesions: 2-year clinical and 6-month imaging outcomes of the
MeRes-1 extend trial
AB 7. Journal of the American College of Cardiology (2019) 64 Patients Multi-centre, prospective, single-arm study Imaging follow-up at 6 months and clinical
follow-up at 2 years
Alexandre Abizaid,
Brazil
AB6. Real world follow-up one year of the novel MeRes100 AB 6. Journal of the American College of Cardiology
(2018)
65 Patients
(81 MeRes100 implanted)
Prospective, single-centre registry 1 Year and OCT at 9 months Marcos Ortega,
Ecuador
AB5. Two-year clinical and imaging outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffolds in de novo coronary artery lesions: the MeRes-1 trial AB 5. Journal of the American College of Cardiology (2018) 108 Patients Prospective, multi-centre, single-arm study 2 Years Ashok Seth,
India
AB4. Real world performance of the novel MeRes100™ AB 4. Journal of the American College of Cardiology (2017) 34 Patients (41 MeRes100 implanted) Prospective,
single-centre,
registry
9 Months Marcos Ortega,
Ecuador
AB3. Favorable outcomes for systemic pharmacokinetic study of sirolimus-eluting bioresorbable vascular scaffold system in treating de novo native coronary artery lesion: A sub study of
MeRes-1 Trial
AB 3. Journal of the American College of Cardiology (2017) 10 Patients Prospective, multi-centre study 90 Days Ashok Seth,
India
AB2. First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial AB 2. Journal of the American College of Cardiology (2017) 108 Patients Prospective,
multi-centre,
first-in-human study
Angiographic follow-up at
6-months, clinical
follow-up at
12 months
Ashok Seth,
India
AB1. Quantitative angiographic analysis in Patients with de novo native coronary artery lesions treated with novel
poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial
AB 1. European Heart Journal
(2017)
108 Patients First-in-man Angiographic follow-up at
6-and 24 months
Ricardo Costa,
Brazil
Review Articles (03)
RA3. Fully bioresorbable vascular scaffolds: Lessons learned and future directions RA 3. Nature Reviews Cardiology
(2019)
- - - Hiroyuki Jinnouchi,
United States of America
RA2. Bioresorbable coronary scaffolds: deployment tips and tricks and the
future of the technology
RA 2. Methodist DeBakey Cardiovascular Journal
(2018)
- - - J. Ribamar Costa,
Brazil
RA1. Bioresorbable scaffold
The emerging reality and future directions
RA 1. Circulation Research
(2017)
- - - Yohei Sotomi,
Netherlands
Book Chapter (01)
BC1. MeRes100™ -A sirolimus eluting bioresorbable vascular
scaffold system
BC 1. In Bioresorbable Scaffolds (2017) - - - Ashok Seth,
India
Editorial/ Editorial Commentary (02)
E1. A fresh look at bioresorbable scaffold technology: Intuition pumps E 1. Indian Heart Journal (2017) - - - Sundeep Mishra,
India
EC2. Can the vanishing stent reappear? Fix the technique, or fix the device? EC 2. Journal of the American College of Cardiology (2017) - - - Spencer B. King,
USA
Mozec™ Rx PTCA Balloon Dilation Catheter-Clinical Publications (Total=05 articles)
Original Research Articles (02)
OR2. Clinical outcomes of a non-compliant balloon dilatation catheter: Mozec™ NC study OR2. International Journal of Environmental Research and Public Health
(2022)
57 of 140 Patients Post-marketing, single-centre, single-arm, retrospective
study
10.40 ± 0.26
months
Akshyaya Pradhan,
India
OR1. Complex coronary interventions with
the novel Mozec™ CTO balloon:
The Mozart registry
OR 1.
Clinical Medicine
Insights: Cardiology
(2015)
41 Patients Prospective non-
randomized, single-arm registry
1 Year Alessandro
Lupi,
Italy
Abstract (01)
AB1. How to make a deal with distal left main coronary artery type a trifurcation lesion AB 1. Journal of the American College of Cardiology (2017) 1 Patient -  - Yusra Pintaningrum,
Indonesia
Review Article (01)
RA1. Drug-coated balloons: technologies and clinical applications RA 1. Current Pharmaceutical Design (2018) - -  - Huiying Ang,
Singapore
Case Report (01)
CR1. Persistent stent thrombosis in a patient with non-ST-segment elevation myocardial infarction and mild COVID-19 CR 1. Journal of Coronary Artery Disease
(2022)
1 Patient - Procedural Details Mehmet Rasih Sonsoz,
Turkey
Metafor™ Sirolimus Eluting Coronary Stent System-Clinical Publications (Total=05 articles)
Original Research Articles (03)
OR 3. Twelve-month clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in
real-world Patients: a single-center experience
OR 3. Indian Heart Journal (2021) 141 Patients Retrospective, single-centre, post-marketing, observational study 1 Year Pankaj Jariwala,
India
OR 2. Safety and performance of sirolimus-eluting coronary stent system with biodegradable
polymer: a retrospective analysis in real-world patient population
OR 2. World Journal of Cardiovascular Diseases (2017) 127 Patients Retrospective, non-randomized, single-center study 3.6 ± 0.6 Years Vithala Surya Prakasa Rao,
India
OR 1. One-year clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary
stent system in Patients with coronary artery disease
OR 1. World Journal of Cardiovascular Diseases (2017) 251 Patients Retrospective, single-center, observational, post-marketing
study
1 Year Sridhar Kasturi,
India
Abstracts (02)
AB 2. Safety and clinical performance of biodegradable polymer-coated sirolimus-eluting coronary stent in
real-world Patients
AB 2. EuroIntervention (2020) 141 Patients Observational, single-center, post-marketing,
retrospective study
1 Year Pankaj Jariwala,
India
AB 1. One-year clinical outcomes of biodegradable polymer coated sirolimus-eluting coronary stent system in Patients with
coronary artery disease
AB.1 Journal of the American College of Cardiology: Cardiovascular interventions
(2017)
251 Patients Retrospective, single center, observational, post-marketing study 1 Year Shridhar Kasturi,
India
NexGen™ Bare Metal Stent-Clinical Publication (Total=01 article)
Abstract (01)
OR 1. Evaluation of safety and efficacy of NexGen-an ultrathin strut and hybrid cell design cobalt-chromium bare metal stent implanted in a real-life patient population-the Polish NexGen™ Registry OR.1 Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej (2016) 383 Patients A prospective, multi-center registry 1 Year Krzysztof Milewski,
Poland
Osum™ Cobalt Chromium Coronary Stent System-Clinical Publication (Total=01 article)
Original Research Article (01)
OR 1. Clinical safety and performance of novel ultra-thin strut cobalt chromium bare metal stent implanted in real-world Patients with coronary artery disease OR.1 International Journal of Current Research
(2018)
467 Patients Observational, non-randomized, retrospective, single-arm study 2 Years Mahesh Basarge,
India
Dafodil™ Pericardial Bioprosthesis-Clinical Publications (Total=02 articles)
Original Research Articles (02)
OR 2. Three-year Outcomes of Surgical Valve Replacement with Dafodil™ Pericardial Bioprosthesis: Dafodil™-1 Trial  OR 2. Frontiers in Cardiovascular
Medicine
(2024)
136 Patients First-in-human, prospective, multi-center study 3 Years

C.S. Hiremath, India

OR 1. Clinical outcomes and hemodynamic performance of Dafodil™ aortic and mitral pericardial bioprosthesis: 1-year results from Dafodil-1 first-in-human trial OR 1. Journal of Cardiothoracic Surgery
(2020)
60 Patients First-in-human, prospective, single-arm, and multi-center trial 1 Year

C.S. Hiremath,
India

CREDENCE™ BtK Sirolimus Eluting Bioresorbable Peripheral Scaffold System-Clinical Publication (Total=01 article)
Abstract (01)
AB 1. 12-month clinical outcomes of sirolimus-eluting bioresorbable peripheral scaffold system following percutaneous transluminal angioplasty of below-the-knee arteries in Patients with critical limb ischaemia: the
CREDENCE™ BtK-1 study
AB.1 EuroIntervention (2020) 30 Patients First-in-man, prospective, multi-centre and open-label study 1 Year Vimal
Someshwar,
India
Menox™ Liquid Embolic System-Clinical Publications (Total=07 articles)
Original Research Article (02)
OR 2. Comparison of a Novel Liquid Embolic System with Commonly Used Embolic Agents in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulas: A Single-Center Experience OR.2 Journal of Clinical Medicine (2024) 11 out of 19 Patients Single center, retrospective study 12 Months Zarko Nedeljkovic, Serbia
OR 1. Intermixed dimethyl-sulfoxide based non adhesive liquid embolic agents delivered serially via the same micro catheter for cerebral AVM treatment OR.1 American Journal of Neuroradiology (2020) 16 Patients Single-centre, prospective study Angiographic mean follow-up of 5.1 months Alexander Sirakov,
Bulgaria
Case Report (02)
CR 2. Embolization Using the Novel Menox Liquid Embolic System for Arteriovenous Fistulas: A Case Report CR 2. Journal of Clinical and Medical Image
(2023)
1 Patient - 6 Months Audrius Sirvinskas,
Lithuania
CR 1. Endovascular treatment of a post-traumatic pseudoaneurysm arising
from a ruptured posterior tibial artery with Menox™ A case report
CR.1 Radiology Case Reports
(2021)
1 Patient - 6 Months Christina Aslanidi,
Greece
Case Series (02)
CS 2. Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox™ in the endovascular treatment of cerebral arteriovenous malformations CS 2. Journal of NeuroInterventional Surgery
(2018)
24 Patients Pilot study, retrospective analysis of prospectively collected data 6 Months Stanimir Sirakov,
Bulgaria
CS 1. Extending endovascular embolization to type A spinal peri-medullary arteriovenous fistula using liquid embolic agent: technical nuances, challenges and initial results CS 1. World Neurosurgery (2018) 3 Cases - - Virender Malik,
India
Review Article (01)
RA 1. Glue, Onyx, Squid or PHIL? Liquid Embolic Agents for the Embolization of Cerebral Arteriovenous Malformations and Dural Arteriovenous Fistulas RA.1 Clinical Neuroradiology
(2022)
- - - Dominik F. Vollherbst,
Germany
Obtura™Vascular Closure Device- Clinical Publication (Total=01 article)
Original Research Article (01)
OR 1. Comparing Obtura Vascular Closure Device to Manual Compression for Achieving Hemostasis After Percutaneous Transfemoral Procedures: A Randomized Study OR 1.
Journal of Endovascular Therapy (2024) 134 out of 268 Patients Prospective, randomized, controlled, multi-center trial 3 Months Tom Devasia, India
 Mammoth Balloon Catheter-Clinical Publication (Total= 01 article)

Original Research Articles (01)

OR 01. Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment OR 01. Journal of Clinical Medicine (2024) 121 Patients Retrospective, single-center cohort analysis Post-procedure Silvia Moscardelli, Italy
ORTHOPEDIC (Total= 11 articles)
Freedom® Total Knee System-Clinical Publications
Original Research Articles (09)
OR 9. A comprehensive comparative study on mid-term clinical and functional outcomes in Indian patients following bilateral total knee arthroplasty: assessing the impact of body mass index on post-total knee arthroplasty results OR 9. International Journal of Research in Orthopaedics (2024) 190 Patients Prospective, multi-center observational study 3 Years Karineravanda M. Ponnanna, India
OR 8. Age wise comparative analysis of Patients undergoing total knee arthroplasty: a multicenter indigenous experience OR 8. International Journal of Research in Orthopaedics
(2024)
300 Patients Prospective, multi-centre, real-world study 3 Years Ravi Teja Rudraraju,
India
OR 7. A multi-centre retrospective study of the impact of body mass index on clinical and functional outcomes of total knee arthroplasty: An Indian prospective OR 7. Journal of Orthopaedic Reports
(2024)
259 Patients Multi-centre retrospective analysis 3 Years Kunal Arneja,
India
OR 6. Efficacy of the pre‑operative
three‑dimensional (3D) CT scan templating in predicting accurate implant size and alignment in robot assisted total knee arthroplasty
OR 6. Indian Journal of Orthopaedics
(2022)
30 Patients Prospective, single-center study - Sanjay Bhalchandra Londhe,
India
OR 5. Early results of bone‑conserving high
flexion posterior‑stabilized total knee system in Indian population
OR 5. Indian Journal of Orthopaedics
(2022)
208 Patients Prospective,
continuous series study
5 Years Sanjay
Bhalchandra Londhe,
India
OR 4. Education, engagement, and provision of empathy by trained counselor enhances the patient satisfaction after
total knee arthroplasty
OR 4. Journal of Clinical Orthopaedics and Trauma
(2020)
200 Patients Prospective, randomized study 52 Weeks Sanjay Bhalchandra Londhe,
India
OR 3. Restoration of femoral condylar anatomy for achieving optimum functional expectations: continuation of an earlier study at 5-year minimum follow-up NA Reconstructive review (2019) 172 Patients Prospective, single-center study 5 Years Sridhar Durbhakula,
India
OR 2. Clinical evaluation of efficacy and performance of all-poly tibial Freedom® total knee system for
treating osteoarthritis Patients: three-year follow up study
OR 2. Journal of Clinical and Diagnostic Research (2017) 158 Patients Retrospective, post-marketing study, single-center 3 Years Avatar Singh,
India
OR 1. Restoration of femoral condylar anatomy for achieving optimum functional expectations: component
design and early results
NA Reconstructive review
(2016)
172 Patients Prospective, non-randomized, single-center study 2 Years with average follow-up of 3.8 ± 0.9
Years
Sridhar Durbhakula,
India
Commentary (01)
CO 1. Challenges in successful management of haemophilic knee arthropathy: our experience in a tertiary center CO.1 Journal of Orthopaedics
(2022)
24 Patients -
1 Year Mohan Thadia,
India
Abstract (01)
AB 1. One-stage total knee arthroplasty with long stemmed tibia for traumatic tibial diaphysis fracture with co-existing osteoarthritis of the knee AB.1 Orthopaedics Proceedings (2022) 3 Patients - 1 Year Sanjay Bhalchandra Londhe,
India
ENDOSURGERY (Total=11 articles)
MERIZELLETM Absorbable Hemostat- Clinical Publication
Original Research Article (01)
OR1. The Safety and Effectiveness of MERIZELLE Oxidized Regenerated Cellulose in Achieving Hemostasis Across Various Surgical Procedures-A Prospective, Multi-Center, Post-Marketing Surveillance Study
NA
Journal of Wound Care (2024) 189
Patients
Prospective, Multi-Center, Post-Marketing Surveillance Study  6 Months Amey Patankar, India
MITSU™ ABP Polyglactin 910 Suture-Clinical Publications (01)
Study Protocol (01)
SP1. Evaluation of safety and efficacy of Polyglactin 910 suture in surgical incision closure: clinical study protocol for a randomized controlled trial SP 1.

International Journal of Clinical Trials (2018) 122
Patients
Prospective, multi-center, randomized, controlled, comparative, post-marketing and single-blinded  6 Months Asha Dixit,
India
MIRUS™ Disposable Haemorrhoids Stapler- Clinical Publications (02)
Original Research Articles (02)
OR2. Clinical outcomes of stapled hemorrhoidopexy using a novel three-row stapler for grade III/IV hemorrhoids: A single-center experience with literature review OR 2. Journal of Clinical Images and Medical Case Reports (2023) 77 Patients Retrospective single centre, cohort study 2 Years M Sadiq Kazi,
India
OR1. Comparison of conventional (CH) vs stapled haemorrhoidectomy (SH):
three-yearss experience
OR 1.

Annals of International Medical and Dental Research
(2017)
150 Patients Retrospective and comparative study 1 Year Kumar Gaurav,
India
Mirus™ Circular Stapler- Clinical Publications (02)
Original Research Article (01)
OR1. Our initial experience of three versus two rows circular stapler devices for stapled hemorrhoidopexy:
a single institution review of 224 cases
OR 1.

International Surgery Journal
(2020)
224 Patients Retrospective, observational, cohort study - Paritosh Gupta,
India
Study Protocol Clinical Trial (01)
SP1. Uni-center, patient-blinded, randomized, 12-month, parallel group, non-inferiority study to
compare outcomes of 3-row vs 2-row circular staplers for colorectal
anastomosis formation after low anterior resection for rectal cancer
SP 1.

Medicine (2019) 154 Patients Prospective, non-inferiority, 2-armed, parallel-group   Nikita A. Nekliudov,
Russia
Fiona™ Intrauterine Contraceptive Device-Clinical Publication (01)
Original Research Article (01)
OR1. Safety and performance of a levonorgestrel-releasing intrauterine contraceptive device: one-year outcomes of Fiona-1 clinical registry OR. 1
Journal of the Indian Medical Association (2019) 309 Patients Prospective, open-label, single-arm post-marketing study 1 Year Jagruti Desai,
India
FILASILK™ Silk Suture-Clinical Publication (01)
Original Research Article (01)
OR1. The safety and efficacy of clipless versus conventional laparoscopic
cholecystectomy-our experience in an Indian rural center
OR 1.

MAEDICA
Journal of Clinical Medicine (2018)
160
Patients
Prospective study 2 Months Rikki Singal,
India
MEGASORB™ Polyglycolic Acid Suture-Clinical Publication (01)
Original Research Article (01)
OR1. Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery:
A clinico-microbiological study
OR 1.

Indian Society of Periodontology (2019) 10 out of 30 Patients Randomized controlled double-blinded study 1 Month Prerna Ashok Karde,
India
MEGASORBPLUS™ Polyglycolic Acid Suture with Chlorhexidine-Clinical Publication (01)
Original Research Article (01)
OR1. Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery: A clinico-microbiological study OR 1.

Indian Society of Periodontology (2019) 10 out of 30 Patients Randomized controlled double-blinded study 1 Month Prerna Ashok Karde,
India
MEGASORB RAPID™ Polyglycolic Acid Suture-Clinical Publication (01)
Original Research Article (01)
OR1. Comparative evaluation of two antibacterial-coated resorbable sutures versus non coated resorbable sutures in periodontal flap surgery:
A clinico-microbiological study
OR 1.

Indian Society of Periodontology (2019) 10 out of 30 Patients Randomized controlled double-blinded study 1 Month Prerna Ashok Karde,
India
ABSOMESH™ Polyglecaprone 25/ Polypropylene Mesh-Clinical Publication (01)
Original Research Article (01)
OR1. A comparative study of open vs laparoscopic repair in umbilical and para umbilical hernias OR 1.

Journal of Dental
and Medical Sciences
(2019)
70 out of 156 Patients Prospective, observational study Post-operative P. Venkata Buddha,
India
DIAGNOSTICS (Total= 3 articles)
EXIMO™ Blood Glucose Monitoring System-Clinical Publication (Total=01 article)
Original Research Article (01)
OR1. A post-marketing surveillance study to evaluate performance of the EXIMO™ blood glucose monitoring system OR 1. Journal of Clinical and Diagnostic Research (2017) 1005
Patients
Non-randomized, single-center, post-marketing study - Sonia R. Chandnani,
India
CelQuant 360™ Automated Haematology Analyser-Clinical Publication (Total=01 article)
Original Research Article (01)
OR1. Comparison between haematological parameters by the Merilyzer Celquant 360™ automated haematology analyser and Sysmex XP-100 haematology analyser with them manual methods OR 1. European Journal of Biomedical and Pharmaceutical Sciences
(2018)
- Comparative, Cross-sectional study - Krishnajyoti Goswami,
Malaysia
ABFIND COVID-19 Neutralizing Antibody Rapid Test-Clinical Publication (Total=01 article)
Original Research Article (01)
OR1. A prospective, single-center study to evaluate the clinical performance of Meril ABFind in individuals vaccinated against Covid-19 OR 1. medRxiv (Preprint)
(2022)
62 Patients Single centre, prospective study - Jayanti Shastri,
India

Disclaimer:

This page is under Construction.

Enquire
Now